Thinking About Quitting My Bioness L300
When I first got my L300 in 2012, it was a blessing. But now it’s more of an annoyance. Back then, the L300 allowed me to walk up and down a grassy slope using just a single cane. I didn’t have to swing my left leg in an arc while I walked. It increased my walking distance and my speed.
Now, more than six years later, I’m using two canes. My overall walking distance and speed have decreased and that grassy slope is nearly impossible, even with two canes and the L300. To put it simply, I’m not getting the bang for the buck that I once got from the cuff. And frankly, it’s a nuisance to strap on and uncomfortable to wear for more than a few hours.
Would an L300 Go be better?
Bioness has replaced the L300 with a newer model, the L300 Go. The new unit has several improvements. It has what Bioness calls “3-D motion detection,” and it doesn’t require a sensor in the user’s shoe. Bioness allowed me to test-walk the L300 Go for about an hour in a clinic before it became available to the public. Frankly, I didn’t think it made enough of a difference to my walking to justify shelling out over $6,000 to buy one; my commercial insurance didn’t cover my current unit and I don’t think Medicare will cover a replacement.
But there’s a problem with failing to upgrade. The older unit is being phased out. When I tested the Go, a Bioness representative told me that the company intends to support the original L300 for “at least the next three years.” So, the clock is ticking.
And customer service at Bioness isn’t what it used to be. Just two months ago, a reader commented:
“I tried for nearly a month to get the upgrade price information. And never received a return call. That was nearly a year ago. Just today, I received an email saying ‘the L300 Go upgrade program is set to expire on October 31st. Act now to take advantage of this offer. Upgrading is as easy as 1, 2, 3.’ So I decided to give it another shot and call. I guess I’m a glutton for punishment. Of course, I couldn’t get through to a rep. Maybe I’ll get an answer before 2020.”
Shortly after this comment was written I, too, tried to reach Bioness to ask about the cost of an upgrade. An email asking about price and trade-in possibility and to be put in touch with a public relations representative went unanswered. (This is a change from earlier years when they were always responsive when I contacted them.)
I have little confidence that my L300 will continue to be supported much longer, especially if I need a repair or a replacement for part of the system.
Can I live without it?
For the past two days, I’ve tried going without my L300. This experiment began because I woke up feeling better than usual. Hauling out a pair of shoes that gave me decent support, I found that I seemed to be walking just as well without the L300 as with it. And I did all day, though a tad slower.
The second day wasn’t as good. I was more tired than usual, and I spent several hours in a car. The result was that I was stiff and slow. Expecting that I’d have a tough day, I’d strapped on the L300 just in case I felt the need for it. And I needed it. I’m glad that I had it.
So, I’m back to square one. The answer to “Can I give it up?” is “Probably not.” At least, not yet. I’d better start saving for a new one.
You’re invited to follow my personal blog at www.themswire.com.
Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.